Highlights
NASDAQ: KZIA       Kazia Therapeutics Ltd
Last Price Today's Change   Day's Range   Trading Volume
4.20   +0.05 (1.20%)  4.10 - 4.20  2,872

Overview

 
Avg Volume (4 weeks):19,733
4 Weeks Range:4.10 - 4.98
4 Weeks Price Volatility (%):
11.36%
52 Weeks Range:2.24 - 9.74
52 Weeks Price Volatility (%):
26.13%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The company has three technologies – PI3K inhibitors, superbenzopyran, and anti-tropomyosin. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; Trilexium, has a potential application across a range of different cancer types.

  Be the first to like this.
 


 

3308  2255  439  2960 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 ACHN 6.760.00 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 PFE 38.30-1.86 
 VXRT 0.861+0.219 
 NIO 4.165+0.155 
 F 8.945+0.055 
Partners & Brokers